9 min listen
E95: Rituximab or Cyclophosphamide in ANCA Vasculitis
E95: Rituximab or Cyclophosphamide in ANCA Vasculitis
ratings:
Length:
21 minutes
Released:
Mar 30, 2023
Format:
Podcast episode
Description
Fun study this week from JAMA Network Open and the French Vasculitis Study Group. They used a target trial emulation (one of my favorites) to ask whether RTX > CYC in AAV (another one of my favorites). I tried to use this to compare between observational and randomized data.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799018
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799018
Released:
Mar 30, 2023
Format:
Podcast episode
Titles in the series (87)
E6: Methylprednisolone and Cyclophosphamide, Alone or in Combinatinon, for Lupus Nephritis: Welcome back! Before we talk about cellcept for lupus nephritis, I decided we should flash back to 1996 and discuss one of the early trials that brought us cyclophosphamide. It's a quick discussion that will help set us up nicely for ALMS this Sunday. ... by The Evidence Based Rheumatology Podcast